Finance 202: Collins’s Indictment Raises Questions About Financial Ethics
But Collins’s status as a member of Congress sets it apart and raises new questions about the propriety of lawmakers both serving on public boards and trading stock. Collins was tipped to the drug trial’s failure because he served on the board of the company— a small Australian biotech firm called Innate Immunotherapeutics— a position that ethics experts…
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
MetLife’s Global Innovation Challenge Returns to Japan: collab 4.0
iPhone Catches on Fire in Man’s Pocket, Causing Severe Burns, says New Lawsuit
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News